Company Listing
SFJ Pharmaceuticals II

SFJ Pharmaceuticals II and Eisai conducted Phase III studies in Asia and other parts of the world of Eisai's thyroid cancer drug, lenvatinib. The product has been approved in the US, Europe and Japan.

 

BACK
Location
Pleasanton, California

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

SFJ Pharmaceuticals II and Eisai conducted Phase III studies in Asia and other parts of the world of Eisai's thyroid cancer drug, lenvatinib. The product has been approved in the US, Europe and Japan.

 

Location
Pleasanton, California
BACK
 
Copyright Abingworth 2017